米国の臨床検査サービス市場調査レポート : 2027年までの予測

出版：Market Research Future（マーケットリサーチフューチャー）　出版年月：2023年1月

US Clinical Laboratory Services Market Research Report Forecast to 2027
米国の臨床検査サービス市場調査レポート : 2027年までの予測

レポート目次　　　　お問合せ・ご注文　　　　価格・納期について

US Clinical Laboratory Services Market Research Report Forecast to 2027

Market Overview
The US clinical laboratory services market is expected to be driven by the increasing prevalence of chronic diseases and growing awareness among people regarding disease management and early diagnosis. Additionally, the growing popularity of personalized medicine will provide growth opportunities for the market in the future. However, the shortage of skilled professionals might hamper market growth during the forecast period.
The US clinical laboratory services market has helped in the early diagnosis of diseases such as cancer, infection, or others can significantly increase the chances of successful treatment at an early stage. The introduction of accurate and technologically advanced products, such as companion diagnostics, biochips, and microarrays, has bolstered the demand for early disease detection. Therefore, it is one of the important public health strategies, where governments and global organizations have started numerous initiatives to generate awareness regarding early diagnosis in the country.
The US clinical laboratory services market is emerging due to the increasing prevalence of chronic diseases and growing awareness among people regarding disease management and early diagnosis. Additionally, the growing popularity of personalized medicine will provide growth opportunities for the market in the future. However, the shortage of skilled professionals might hamper the market growth during the forecast period.

Market Segmentation
The US Clinical Laboratory Services market, based on application, has been segmented into independent laboratory, reference laboratory, and hospital laboratory.
Based on type the US clinical laboratory services market is segmented into biochemistry, endocrinology, microbiology, hematology, histopathology, cytology, and genetic testing.

Major Players
The key players profiled in the US clinical laboratory services market are Laboratory Corporation of America Holdings, Mayo Medical Laboratories, Quest Diagnostics Incorporated, Eurofins Scientific, and Sonic Healthcare Limited.
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

目次

TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING PREVALENCE OF CHRONIC DISEASES
4.2.2 GROWING AWARENESS AMONG PEOPLE REGARDING DISEASE MANAGEMENT AND EARLY DIAGNOSIS
4.3 RESTRAINT
4.3.1 SHORTAGE OF SKILLED PROFESSIONALS
4.4 OPPORTUNITY
4.4.1 GROWING POPULARITY OF PERSONALIZED MEDICINE
4.5 VALUE CHAIN ANALYSIS
4.5.1 CUSTOMER ACQUISITION (PREPURCHASE QUERY)
4.5.2 SERVICE CUSTOMIZATION
4.5.3 CUSTOMER PURCHASE SUPPORT
4.5.4 CUSTOMER FULFILMENT & POST-PURCHASE SUPPORT
4.6 PORTER’S FIVE FORCES MODEL
4.6.1 THREAT OF NEW ENTRANTS
4.6.2 BARGAINING POWER OF SUPPLIERS
4.6.3 THREAT OF SUBSTITUTES
4.6.4 BARGAINING POWER OF BUYERS
4.6.5 INTENSITY OF RIVALRY
4.7 IMPACT OF COVID-19 ON CLINICAL LABORATORY SERVICES MARKET
4.7.1 OVERVIEW
4.7.2 IMPACT ON PRICING
4.7.3 IMPACT ON KEY PLAYERS
5 US CLINICAL LABORATORY SERVICES MARKET BY TYPE
5.1 OVERVIEW
5.2 BIOCHEMISTRY
5.3 ENDOCRINOLOGY
5.4 MICROBIOLOGY
5.5 HEMATOLOGY
5.6 HISTOPATHOLOGY
5.7 CYTOLOGY
5.8 GENETIC TESTING
5.9 OTHERS
6 US CLINICAL LABORATORY SERVICES MARKET BY APPLICATION
6.1 OVERVIEW
6.2 INDEPENDENT LABORATORY
6.3 REFERENCE LABORATORY
6.4 HOSPITAL LABORATORY
7 COMPETITIVE LANDSCAPE
7.1 OVERVIEW
7.2 COMPETITIVE BENCHMARKING
7.3 MAJOR GROWTH STRATEGY IN THE US CLINICAL LABORATORY SERVICES MARKET
7.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE US CLINICAL LABORATORY SERVICES MARKET
7.5 KEY DEVELOPMENT ANALYSIS
7.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
7.6.1 SERVICE LAUNCHES
7.6.2 PARTNERSHIPS/ACQUISITIONS/COLLABORATIONS
7.6.3 EXPANSIONS/AGREEMENTS
7.7 FINANCIAL MATRIX
7.7.1 SALES (USD MILLION), 2020
7.7.2 R&D EXPENDITURE (USD MILLION), 2020
8 COMPANY PROFILE
8.1 MAYO MEDICAL LABORATORIES
8.1.1 COMPANY OVERVIEW
8.1.2 FINANCIAL OVERVIEW
8.1.3 SERVICES OFFERED
8.1.4 KEY DEVELOPMENTS
8.1.5 SWOT ANALYSIS
8.1.6 KEY STRATEGIES
8.2 LABORATORY CORPORATION OF AMERICA HOLDINGS (LABCORP)
8.2.1 COMPANY OVERVIEW
8.2.2 FINANCIAL OVERVIEW
8.2.3 SERVICES OFFERED
8.2.4 KEY DEVELOPMENTS
8.2.5 SWOT ANALYSIS
8.2.6 KEY STRATEGIES
8.3 QUEST DIAGNOSTICS INCORPORATED
8.3.1 COMPANY OVERVIEW
8.3.2 FINANCIAL OVERVIEW
8.3.3 SERVICES OFFERED
8.3.4 KEY DEVELOPMENTS
8.3.5 SWOT ANALYSIS
8.3.6 KEY STRATEGIES
8.4 SPECTRA LABORATORIES INC.
8.4.1 COMPANY OVERVIEW
8.4.2 FINANCIAL OVERVIEW
8.4.3 SERVICES OFFERED
8.4.4 KEY DEVELOPMENTS
8.4.5 KEY STRATEGIES
8.5 EUROFINS SCIENTIFIC
8.5.1 COMPANY OVERVIEW
8.5.2 FINANCIAL OVERVIEW
8.5.3 SERVICES OFFERED
8.5.4 KEY DEVELOPMENTS
8.5.5 SWOT ANALYSIS
8.5.6 KEY STRATEGIES
8.6 SONIC HEALTHCARE LIMITED
8.6.1 COMPANY OVERVIEW
8.6.2 FINANCIAL OVERVIEW
8.6.3 PRODUCTS/SERVICES OFFERED
8.6.4 KEY DEVELOPMENTS
8.6.5 SWOT ANALYSIS
8.6.6 KEY STRATEGIES
8.7 NEOGENOMICS LABORATORIES, INC.
8.7.1 COMPANY OVERVIEW
8.7.2 1.2.2 FINANCIAL OVERVIEW
8.7.3 PRODUCTS/SERVICES OFFERED
8.7.4 KEY DEVELOPMENTS
8.7.5 1.2.6 KEY STRATEGIES
8.8 FRESENIUS MEDICAL CARE AG & CO. KGAA
8.8.1 COMPANY OVERVIEWS
8.8.2 1.2.2 FINANCIAL OVERVIEW
8.8.3 PRODUCTS/SERVICES OFFERED
8.8.4 1.2.4 KEY DEVELOPMENTS
8.8.5 KEY STRATEGIES
8.9 CLINICAL REFERENCE LABORATORY
8.9.1 COMPANY OVERVIEW
8.9.2 FINANCIAL OVERVIEW
8.9.3 PRODUCTS/SERVICES OFFERED
8.9.4 KEY DEVELOPMENTS
8.9.5 KEY STRATEGIES
8.10 OPKO HEALTH, INC. (BIOREFERENCE LABORATORIES)
8.10.1 COMPANY OVERVIEW
8.10.2 FINANCIAL OVERVIEW
8.10.3 PRODUCTS/SERVICES OFFERED
8.10.4 1.2.4 KEY DEVELOPMENTS
8.10.5 KEY STRATEGIES
9 APPENDIX
9.1 REFERENCES
9.2 RELATED REPORTS

LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
TABLE 3 US: CLINICAL LABORATORY SERVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 4 US: CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 5 MAJOR PLAYERS IN THE US CLINICAL LABORATORY SERVICES MARKET
TABLE 6 MOST ACTIVE PLAYER IN THE US CLINICAL LABORATORY SERVICES MARKET
TABLE 7 SERVICE LAUNCHES
TABLE 8 PARTNERSHIPS/ACQUISITIONS/COLLABORATIONS
TABLE 9 EXPANSIONS/AGREEMENTS
TABLE 10 MAYO MEDICAL LABORATORIES: SERVICES OFFERED
TABLE 11 MAYO MEDICAL LABORATORIES: KEY DEVELOPMENTS
TABLE 12 LABCORP: SERVICES OFFERED
TABLE 13 LABCORP: KEY DEVELOPMENTS
TABLE 14 QUEST DIAGNOSTICS INCORPORATED: SERVICES OFFERED
TABLE 15 QUEST DIAGNOSTICS INCORPORATED: KEY DEVELOPMENTS
TABLE 16 SPECTRA LABORATORIES, INC.: SERVICES OFFERED
TABLE 17 SPECTRA LABORATORIES, INC.: KEY DEVELOPMENTS
TABLE 18 EUROFINS SCIENTIFIC: SERVICES OFFERED
TABLE 19 SONIC HEALTHCARE LIMITED: PRODUCTS/SERVICES OFFERED
TABLE 20 SONIC HEALTHCARE LIMITED: KEY DEVELOPMENTS
TABLE 21 NEOGENOMICS LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED
TABLE 22 NEOGENOMICS LABORATORIES, INC.: KEY DEVELOPMENTS
TABLE 23 FRESENIUS MEDICAL CARE AG & CO. KGAA: PRODUCTS/SERVICES OFFERED
TABLE 24 FRESENIUS MEDICAL CARE AG & CO. KGAA: KEY DEVELOPMENTS
TABLE 25 CLINICAL REFERENCE LABORATORY: PRODUCTS/SERVICES OFFERED
TABLE 26 OPKO HEALTH, INC. (BIOREFERENCE LABORATORIES): PRODUCTS/SERVICES OFFERED
TABLE 27 OPKO HEALTH, INC. (BIOREFERENCE LABORATORIES): KEY DEVELOPMENTS

LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 US CLINICAL LABORATORY SERVICES MARKET
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
FIGURE 4 MARKET DYNAMICS: US CLINICAL LABORATORY SERVICES MARKET
FIGURE 5 DRIVERS: IMPACT ANALYSIS
FIGURE 6 RESTRAINTS: IMPACT ANALYSIS
FIGURE 7 VALUE CHAIN ANALYSIS: CLINICAL LABORATORY SERVICES MARKET
FIGURE 8 PORTER’S FIVE FORCES ANALYSIS: US CLINICAL LABORATORY SERVICES MARKET
FIGURE 9 US CLINICAL LABORATORY SERVICES MARKET, BY TYPE, 2020 & 2027 (USD MILLION)
FIGURE 10 US CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2020 & 2027 (USD MILLION)
FIGURE 11 BENCHMARKING OF MAJOR COMPETITORS
FIGURE 12 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE US CLINICAL LABORATORY SERVICES MARKET
FIGURE 13 US CLINICAL LABORATORY SERVICES MARKET: COMPETITIVE LANDSCAPE
FIGURE 14 SALES (USD MILLION), 2020
FIGURE 15 R&D EXPENDITURE (USD MILLION) 2020
FIGURE 16 MAYO MEDICAL LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 MAYO MEDICAL LABORATORIES: SWOT ANALYSIS
FIGURE 18 LABCORP: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 LABCORP: SWOT ANALYSIS
FIGURE 20 QUEST DIAGNOSTICS INCORPORATED: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 QUEST DIAGNOSTICS INCORPORATED: SWOT ANALYSIS
FIGURE 22 EUROFINS SCIENTIFIC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 EUROFINS SCIENTIFIC: SWOT ANALYSIS
FIGURE 24 SONIC HEALTHCARE LIMITED: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 SONIC HEALTHCARE LIMITED: SWOT ANALYSIS
FIGURE 26 NEOGENOMICS LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 FRESENIUS MEDICAL CARE AG & CO. KGAA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 OPKO HEALTH, INC. (BIOREFERENCE LABORATORIES): FINANCIAL OVERVIEW SNAPSHOT